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Abstract 
With the increased attention on bio-based industry, demands for techniques that enable fast and effective strain 
improvement have been dramatically increased. Evolutionary engineering, which is less dependent on biological 
information, has been applied to strain improvement. Currently, synthetic biology has made great innovations in evo-
lutionary engineering, particularly in the development of synthetic tools for phenotypic perturbation. Furthermore, 
discovering biological parts with regulatory roles and devising novel genetic circuits have promoted high-throughput 
screening and selection. In this review, we first briefly explain basics of synthetic biology tools for mutagenesis and 
screening of improved variants, and then describe how these strategies have been improved and applied to pheno-
typic engineering. Evolutionary engineering using advanced synthetic biology tools will enable further innovation 
in phenotypic engineering through the development of novel genetic parts and assembly into well-designed logic 
circuits that perform complex tasks.
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Background
Synthetic biology aims to create or redesign new biologi-
cal systems to achieve specific purposes. Comparing with 
traditional bioengineering, synthetic biology is based 
on the prediction and design. Evolutionary engineer-
ing focuses on obtaining desired functions of a system 
through overcoming a lack of information. Especially, the 
complex functions required for industrial strains such 
as optimized production pathway, tolerance of product, 
and genomic stability are difficult to gain with ration-
ally assigned modifications only. Therefore, generating 
massively diverse phenotypes and screening improved 
variants out of them can circumvent the limitation. Evo-
lutionary engineering mimics Darwinian selection, and 
the beneficial phenotypes are propagated to offspring. 
Thus, the addition of appropriate selection pressure is a 
key factor to the acquisition of the desired phenotype.
In this aspect, synthetic biology can provide tools to 
accumulate genetic mutations and to link or convert 
these genotypes into detectable phenotypes. Recently, 
techniques for phenotypic perturbation such as tran-
scription/translation machinery engineering, CRISPRi/a, 
sRNA, MAGE derived techniques, error-prone replica-
tion machinery, and genome shuffling were demonstrated 
[1–12]. In addition, phenotypic-specific biosensor/selec-
tor, biomolecule compartmentalization technique, and 
obtaining desired function based on phage progeny were 
developed. To provide further understanding and insight, 
recently developed techniques of synthetic biology used 
to evolve microorganisms to achieve the desired pheno-
type will be summarized in this review.
Phenotypic perturbation
Rewiring protein expression or modifying specific 
activity of a protein causes phenotypic perturbation. 
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In general, cellular traits which are required to be uti-
lized in the industry are difficult to be shown because 
flux redirection and biochemical accumulation in a cell 
decrease cellular fitness. High-throughput, intensive, 
multiplex genetic mutations can expand the phenotype 
spaces enough to bring desired phenotype.
Transcriptional regulation perturbation
Synthetic biology techniques can provide synthetic tran-
scription factors to elicit de novo regulation. One of the 
examples is an artificial transcription factor which has 
new regulatory functions in a cell. Park et al. constructed 
artificial transcription factor (TF) library capable of ran-
dom regulation of endosomes gene expression (Fig.  1a) 
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Fig. 1 Phenotypic perturbation methods. a, b Represent methods to alter transcriptional regulation. a Artificial TF and gTME library; transformation 
with artificial transcription factor or of global transcription machinery libraries that are generated by error-prone PCR results in phenotypic 
perturbation by unpredictable regulation changes. b CRISPRi/a; transformation with guide RNA (gRNA) plasmid array and dCas9 repressor/activator 
results in alter cellular regulations. c Perturbation of translational expression level through binding of sRNA and RNA binding protein. Expression 
of multiple sRNAs can repress multi-gene expression. d Representative two method for in vitro mutagenesis. A error-prone PCR introduce 
mutations during PCR and PCR with oligos harboring degenerate sequence diversify DNA sequence after being assembled. e MAGE technique 
introduces multiple mutations in genome through automation of iterative synthetic oligo recombineering. f ICE generate mutated DNA in vivo. 
A designed cassette composed of transposable element and target gene (CARGO) is transcribed and then reverse transcribed in an error-prone 
manner. The resulting cDNA is integrated back into the chromosome. d, g are methods to introduce mutations on target region. g EvolvR consists 
of a DNA polymerase fused with nCas9 which is recruited by gRNA into target region. After a DNA is nicked by the nCas9, the error-prone DNA 
polymerase performs error-prone strand displacement synthesis. h MutaT7 consists of a cytidine deaminase fused to T7 RNA polymerase. It is 
recruited to T7 promoter and mutations are loaded during transcription before transcription is terminated by terminator. i A plasmid carrying proof 
reading deficient DnaQ and factors conferring replication fidelity generates mutations during cell growth. j The pre-positioned loxPsym sites are 
recombined, inverted, and deleted by Cre induction and results various phenotypes
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[9]. The library contained more than 100,000 artificial 
transcription factors, each of which consisted of zinc fin-
ger domains with different binding specificities and tran-
scriptional activator or repressor domain. The artificial 
transcription factors could bind endogenous DNA ran-
domly, so when it binds a specific locus with regulatory 
role, cellular metabolic network would be perturbed.
Cells regulate the metabolic network with multiple reg-
ulation factors to suit specific environments and cellular 
state. Rewiring the innate regulation leads cells to new 
phenotypes. Alper et  al. aimed to change interactions 
between host transcription factors (TF) and their targets 
(Fig.  1a) [1]. The evolutional potent of global transcrip-
tion machinery was demonstrated by global transcription 
machinery engineering (gTME). One of the transcription 
machineries, TATA-binding protein encoded in SPT15 
was chosen to generate library by error-prone PCR. The 
library was cultured under high ethanol concentration as 
selection pressure, and tolerant variants were selected. 
The effect of combined mutations on host global tran-
scription factors brought differential gene expressions of 
hundreds of genes compared to wild-type cells, and these 
simultaneous alterations of multigene expression elic-
ited improved phenotype. The gTME was employed for 
mutagenesis of both model strain (Saccharomyces cerevi-
siae) and non-model strain (Yarrowia lipolytica). A spt15 
variant which brought ethanol-tolerant phenotype to S. 
cerevisiae was screened, and the effect on physiology was 
analyzed. The screened spt15 variant was more resist-
ant to osmotic shock, and growth inhibition was smaller 
than that of wild-type SPT15 when glucose was fed at a 
high concentration [13]. This is a great advantage in the 
fed-batch culture, but the changes in metabolic regula-
tions still have to be analyzed. S. cerevisiae which is more 
tolerant to crude substrates, corn cob acid hydrolysates, 
and metabolizes xylose was screened from spt15 library 
[14]. Transcriptome, metabolic flux analysis, and phe-
notyping were performed by Wadhwa et al. on the spt15 
mutant screened from their previous study. They found 
that the spt15 mutant affected phosphate limitation, 
which rewired central carbon metabolism and increased 
flux to the isoprenoid pathway [15, 16]. Moreover, the 
applicability of gTME was demonstrated in Y. lipolytica 
to modulate phenotype by expressing additional Yl-spt15 
variants without deleting original transcription factor. 
The accumulation of fatty acids and lipid bodies was 
influenced by the gene expression ratio of the wild-type 
SPT15 and Yl-spt15 variants as well as the mutations on 
Yl-SPT15 [17]. There are also several successful studies 
applying gTME to improve Escherichia coli phenotypes 
such as high hyaluronic acid production and organic-
solvent tolerance [1, 18]. In these studies, mutant librar-
ies of major sigma factors, E. coli rpoD and/or rpoS, were 
screened under appropriate selection pressure.
In addition to the studies based on the host TF, an exog-
enous transcriptional regulator was employed for gTME. 
The regulators of a radio-resistant bacterium, Deinococ-
cus radiodurans, have often been used to bring diverse 
tolerance in E. coli. The tolerance of E. coli to multiple 
stress was increased by introducing one of the global 
regulators, IrrE or response regulator, DR1558 from D. 
radiodurans [19, 20]. Although transcriptome and pro-
teome of ethanol-tolerant strain screened from irrE 
mutant library have been altered, the exact mechanism 
that gives tolerance remained to be unveiled [5]. Artifi-
cial TFs and gTME technique usually change expression 
level of a tremendous number of genes in unpredictable 
mechanism. To traverse more guided phenotype space, 
targeted cellular reprogramming is also regarded as an 
efficient strategy to generate desired phenotype. One 
of the traditional methods is to generate combinatorial 
library by replacing promoters of target genes to other 
synthetic promoters with different strengths. Blazeck 
et al. selected genes involved in lipogenesis, and the over-
expression or deletion of these target genes showed dif-
ferent amounts of lipid accumulation [21]. Although they 
succeeded in improving strains to increase the total lipid 
production by 60 times, there are still some limitations to 
search large phenotype spaces due to low-efficiency and 
laborious recombination steps.
A nuclease-deficient Cas9 protein-based transcrip-
tional interference/activation system, CRISPRi/a, 
Table 1 List of helper enzymes
Target product Regulatory protein/detection method Helper enzyme Detectable chemical References
3-HP PrpR (Escherichia coli) Pcs, PrpC 2-Methylcitrate [71]
3-HP AcuR (Rhodobacter sphaeroides) pcs mutant, ach Acrylate [71]
1,3-PDO MmsR (Pseudomonas denitrificans) KgsA mutant 3-HP [72]
ω-Amino fatty acids NitR (Alcaligenes faecalis) Cyclase Lactam [73]
Tyrosine Dark pigment MelA (Rhizobium etli) Melanin [74]
Malonyl-CoA Colorimetric indicator RppA (Streptomyces griseus) FLAVIOLIN [75]
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made it possible to modulate expression level of tar-
get genes without replacing their promoters (Fig.  1b) 
[10]. Using both dCas9-repressor and dCas9-activator, 
Deaner et al. enabled regulation of target gene expres-
sion in graded manner within a wide range based 
on the distance between a target location and a core 
promoter, which affects the regulation fold-change. 
They applied CRISPRi/a system to systematically test 
enzyme perturbation sensitivities (STEPS), and rapidly 
improved glycerol and 3-dehydroshikimate (3-DHS) 
production in yeast [22]. However, a dCas9-repressor 
and a dCas9-activator share their gRNAs, which limits 
their ability to program the expression levels of mul-
tiple genes in a cell. To overcome this limitation, it 
was examined whether the dCas9-activator could also 
role as a repressor depending on the binding location. 
Accompanied with a ribozyme-sgRNA array, bifunc-
tional role of the dCas9-activator enhanced multiplex-
ing power of CRISPRi/a in yeast [23].
CRISPRi/a techniques have also been adopted to 
optimize expression levels of multiple endogenous 
genes in prokaryotes (Fig.  1b). Wang et  al. screened 
high-lycopene-producing-E. coli among knockdown 
library targeting 56 phosphatase-encoding genes 
which were systematically identified [24]. Using com-
binations of sgRNAs which were targeting different 
genes and different locations, Wu et  al. dynamically 
optimized expression levels of three genes in the com-
peting pathways for the production of N-acetylglu-
cosamine in Bacillus subtilis [25]. Bikard et  al. first 
demonstrated that the fusion of the ω-factor of E. coli 
RNAP, encoded in rpoZ, to dCas9 enabled implement-
ing CRISPRa system in prokaryote [3]. Later, Dong 
et al. developed an improved version of CRISPRa sys-
tem for prokaryote. They utilized gRNA incorporating 
MS2 aptamer (scRNA) which recruited SoxS activator 
fused with MS2 coat protein (MCP-SoxS) to the tar-
get region; so, miss-folding risk from fusion of dCas9 
with large protein domain was eliminated [7]. With 
the information, it is possible to construct the library 
based on these CRISPRi/a systems to search phe-
notypic space, and the size of the space is depending 
on the variability of the guide sequences of sgRNAs. 
Recently, E. coli genome-scale guide sequence library 
has been developed and used to screen the genes 
conferring toxic chemical tolerances [26]. Accompa-
nied with the genome-scale guide sequence library, 
advanced gene assembly methods allow the CRISPRi/a 
system to be one of the most efficient tools to generate 
phenotypic perturbations [27–29]: CRISPathBrick (E. 
coli up to 5 gRNAs), CRISPR-LEGO (S. cerevisiae up 
to 5 gRNAs), and ASAP-cloning (mammalian cell up to 
9 gRNAs).
Translational regulation perturbation
To explore more diverse phenotypes with less laborious 
experiments, a library should be small in size but cover 
wide range of expression levels. Based on the predictive 
design tools for 5′untranslated region (5′UTR) [30, 31], 
algorithms were developed to generate the degenerate 
5′UTR sequence covering a defined range of translation 
initiation rate (TIR) [32, 33]. Moreover, a RedLibs algo-
rithm was proven to generate smallest library with uni-
formly discrete TIRs [34]. RedLibs reduced the risk and 
effort of the analysis step by minimizing the size of library 
through leaving the sequences meaningful to investigate 
only. The aforementioned methods generate a library 
resulting a subtle sequence change in the relatively nar-
row region such as ribosome-binding sites (RBSs). Due 
to a small change in DNA sequence, these mutations 
can be restored by DNA mismatch repair (MMR) sys-
tem during replication in bacteria. The adverse effect of 
MMR system on the library generation had been exam-
ined, and removal of MMR system increased recombina-
tion efficiency using single-stranded DNA (ssDNA) [12, 
35]. On the other hand, removal of MMR system resulted 
in an unintended increase in background mutation rate. 
Using ssDNA containing chemically modified bases 
could be an alternative strategy to improve oligo-medi-
ated recombination [36]. Recently, genome-library-opti-
mized-sequences (GLOS) design rule enabled sufficient 
recombineering in MMR-proficient strain with ssDNA 
by remaining only sequence variants carrying more 
than 6 base pairs (bp) mismatch at the targeted region 
[37]. Despite the development of recombineering-based 
library generation strategies, genome-scale multiplexing 
engineering is still limited.
Na et  al. demonstrated that rationally designed syn-
thetic small regulatory RNA (sRNA) could be served as 
a tool to control translation efficiency of multiple tar-
get genes simultaneously for genome-wide screening of 
the desired phenotype (Fig. 1c) [8]. Noh et al. advanced 
sRNA-mediated regulation system. To precisely tune tar-
get gene expression, they modulated a content of sRNA 
in a cell [38]. To fine-tune the level of multiple gene 
expression, a larger size comparing to a knock-down 
library with the same number of targets is required. A 
novel method using predetermined orthogonal sRNA-
target sequence pool enabled balancing the expression 
levels of multiple genes composing a synthetic pathway. 
By assembling the pathway with gene cassette carrying 
a sRNA-target sequence around the TIR of each gene, 
the gene expression levels could be diversified with pre-
built sRNA library that consisted of several sRNAs with 
different transcription levels [39]. With this method, the 
designed beta-Carotene production pathway was effi-
ciently optimized using reusable sRNA pool.
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An orthogonal translation system is a fundamental 
requirement to reprogram cellular gene regulation by 
incorporation of non-natural amino acids in target pro-
tein or expand genetic code. Researchers attempted to 
develop orthogonal ribosome and orthogonal aminoacyl 
tRNA synthetase/tRNA set. The nature of a ribosome 
consisting of two subunits makes it difficult to modify 
ribosome functionality. Although a mutant 30S subu-
nit with changed elongation property and modified 16S 
rRNA to recognize alternative Shine–Dalgarno sequence 
was constructed, the engineering 50S subunit was lim-
ited because of the interference in orthogonal subsets. To 
circumvent these limitations, a tethered ribosome (Ribo-
T) and stapled orthogonal ribosome where the large and 
small subunit rRNAs are linked were demonstrated [40, 
41].
Directed evolution of CDS/specific locus/plasmid
Evolutionary engineering of protein or plasmid is one of 
the key methods to improve protein activity and cellular 
phenotype. Furthermore, intensive protein-directed evo-
lution could create superior functionality such as solvent 
tolerance and non-natural function [42]. An error-prone 
PCR or assembly methods with DNA fragments harbor-
ing degenerate sequences are generally used to create 
mutated proteins in a broad region or a specific position, 
respectively (Fig. 1d). Usually these methods are accom-
panied with transformation and in vivo selection step.
Multiplex automated genome engineering (MAGE) 
demonstrated that combinatorial sequence changes 
could be introduced at multiple loci in E. coli genome 
(Fig.  1e) [12]. Using synthetic 90-mer oligo pools con-
taining degenerate sequences, a simple automated cycle 
consisting of three steps (cell growth and recovery, mak-
ing recombination-competent cell, and electroporation 
step) was repeated to generate genetic diversity. How-
ever, the recombination efficiency of each MAGE cycle 
was dropped by less than 2% when inserting more than 
20 bp in sequence. Thus, direct replacement of multiple 
promoters in genome was laborious and time-consum-
ing. Selecting more recombination-competent cells, co-
selection MAGE (CoS-MAGE) overcame this limitation 
[43]. Selection steps using selection markers dispersed 
throughout the genome increased the insertion effi-
ciency up to 25% at the region near the selection marker. 
Using advanced selection strategy, they combinatorially 
replaced 12 native promoters on the genome with T7 
promoter. After all the efforts to increase recombination 
efficiency, indirect selection methods were not sufficient 
for recursive recombination to introduce mutations into 
the genome. Therefore, Ronda et  al. improved the effi-
ciency of MAGE-based recombination by implementing 
CRISPR/Cas9-based selection [44]. While performing 
the CRISPR-optimized MAGE-recombineering, cells 
with altered target DNA sequences could survive only.
Despite the high increase in recombineering efficiency, 
the CRISPR/Cas9-based selection methods could target 
single loci at each MAGE cycle. High-throughput oligo 
pool synthesis and automated recombineering enabled 
incorporating mutations to multiple genomic regions. 
Garst et  al. developed a method that could not only 
generate genetic perturbation efficiently but also iden-
tify the modified region by barcode in the genome-scale 
[45]. CRISPR-enabled trackable genome engineering 
(CREATE) was based on the design of a synthetic cas-
sette composing both homology arms for recombina-
tion and cognate gRNA for selection. After the CREATE 
cycle proceeds, the mutations can be traced by sequenc-
ing the plasmid from enriched population or cell. This 
strategy was successfully demonstrated in screening for 
mutations that confer acetate or furfural tolerance from 
CREATE libraries. Liu et  al. demonstrated iterative use 
of CREATE system by adding the gRNA plasmid curing 
step, iCREATE, to elicit combinatorial mutations that 
permit epistasis [46]. Repeated CREATE cycles using 
RBS library or pre-determined 28 genes library enhanced 
hydrolysate tolerance.
Transformation step introducing genetic variants cre-
ated by in vitro methods into cells is regarded as a lim-
iting step of directed evolution. In  vivo continuous 
generation and accumulation of mutations can accelerate 
directed evolution. To accomplish this, in  vivo continu-
ous evolution (ICE) was demonstrated by Crook et  al. 
(Fig. 1f ) [6]. ICE is a retro element-based method which 
could generate mutations with error-prone nature and 
be re-integrated into a stable genetic element. Several 
parameters such as CARGO expression level, host factor, 
transposase induction conditions, and overexpression of 
initiator tRNA were investigated to elevate transposition. 
Compared with error-prone PCR, key factors such as 
subculture frequency, growth rate, and final  OD600 of the 
resulting clones were higher, indicating outperformance 
of ICE to mutagenesis. Although this system can be 
implemented in other yeast strains, the absence of trans-
position system that enables re-integration into origi-
nated locus makes it difficult to be performed in E. coli. 
Simon et al. demonstrated a similar system in E. coli [47]. 
Combined use of retroelement of E. coli and error-prone 
T7 RNA polymerase allowed a continuous mutagenesis 
in E. coli. However, relatively low efficiency of re-integra-
tion and narrow region that was targeted to be overwrit-
ten were remained to be solved.
In vivo random mutagenesis was developed using 
error-prone DNA polymerase I (Pol I) that is responsi-
ble for the replication of ColE1 origin of replication [4]. 
Although Pol I is involved in lagging strand synthesis 
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during replication of chromosome, it can also initiate 
replication from the ColE1 origin. Therefore, mutations 
would be loaded in sequences on a ColE1-containing 
plasmid by error-prone Pol I during plasmid replication. 
Mutations occurred up to 3 kb away from the origin, but 
the rate decreased after 650 bp. This system also showed 
biased substitution of bases.
The mutagenesis system that is highly error prone dur-
ing replication of the entire plasmid but for chromo-
some was developed in yeast. Ravikumar et  al. applied 
the orthogonal plasmid replication protein–DNA pair 
(p1-TPDNAP1) from pGKL1/2 which is the cytoplas-
mic plasmid system of Kluyveromyces lactis to yeast [11]. 
They modified p1 plasmid to introduce gene of inter-
est and increase error rate of the plasmid using cognate 
DNAP (TP-DNAP1) variants without increasing the 
genomic mutation rate during replication. Arzuman-
yan et  al. reported a development of extrachromosomal 
error-prone replication system using both of pGKL1-TP-
DNAP1 and pGKL2-TP-DNAP2. This method may be 
applied to directed evolution of enzymes with different 
error rate in a cell [2]. Recently, Ravikrmar advanced the 
previously reported error-prone orthogonal plasmid sys-
tem for high error rates which exceed mutation-induced 
extinction threshold (4.72  ×  10−6 s.b.p. for yeast) [48]. 
The advanced OrthoRep, an orthogonal DNA polymer-
ase–plasmid pair replicated in error-prone manner, con-
sisted of TP-DNAP1 variant which was screened for high 
error rate and showed around 100,000-fold faster error 
rate than chromosome. In addition, it was demonstrated 
that copy number of p1 could be controlled by express-
ing replication-deficient TP-DNAP1 variants as a com-
petitor. The utility of the highly error-prone and stable 
mutagenic TP-DNAP1 was demonstrated by evolution 
of Plasmodium falciparum dihydrofolate reductase (PfD-
HFR) to be resistant to pyrimethamine, an antimalarial 
drug. High-throughput evolution of PfDHFR, 90 inde-
pendent replicates, made it possible to trace evolutionary 
path and complex fitness landscape of drug resistance.
Random mutation at the targeted region
Introducing mutations at the designed positions such 
as promoters, coding regions or regulatory noncoding 
RNA sequences could be an effective method to expand 
phenotypic space. Although in vitro assembly of genetic 
fragments is generally used for site-specific saturation 
mutagenesis, the library size is limited by transformation 
efficiency. An iterative use of MAGE-derived techniques 
can generate saturated mutations into specific loci; it 
is still limited by transformation and recombineering 
efficiency.
Thus, several synthetic biology tools have been 
developed to overcome the limitations of in  vitro 
mutagenesis and to efficiently generate mutations on 
the intended regions. Recently developed three syn-
thetic tools are introduced in this section. In these 
methods, the functional proteins are recruited on the 
target region depending on the interactions between 
nucleic acids and proteins. Nishida et  al. developed 
a method that could target activation-induced cyti-
dine deaminase (AID) activity to specific locus in yeast 
and mammalian cells [49]. The gRNA recruited Tar-
get-AID, a complex of nickase Cas9 (nCas9) and AID 
(PmCDA1), at target sequence, and the linked AID 
generated mutations on the target position. Depending 
on the gRNA sequence, Target-AID could recruit any 
locus without any change in genetic background; thus, 
it is useful for introducing specific mutations (C to T) 
in a narrow range.
In addition to development of base-editor, Halperin 
et  al. developed a mutator, EvolvR, which not only tar-
geted user-defined region but also generated more vari-
able sequence changes in a wider range [50]. A fusion 
protein with an error-prone DNA polymerase (DNAP) 
and nCas9 was devised, and then nCas9 affinity was 
modified to enhance mutagenesis (Fig.  1g). The DNAP 
was also engineered to get a different mutation rate, and 
additional fusion of thioredoxin-binding domain (TBD) 
could increase the length of the mutable window. These 
mutator variants allowed users to tune mutation rate. In 
addition, DNAP was replaced with a Phi29 polymerase 
mutant, a processive polymerase with reduced fidelity, to 
increase the tunable window up to 350 bp from PAM.
Another powerful method, MutaT7, was developed 
which could generate mutations in targeted region [51]. 
Comparing with EvolvR, the MutaT7 in which a cytidine 
deaminase (rApo1) fused to T7 RNAP was recruited tar-
geted region by T7 RNAP and T7 promoter interaction 
(Fig.  1h). The mutations were loaded at targeted region 
whenever T7 RNAP processed transcription; so strong 
T7 promoter could show higher mutation rate. Like Tar-
get-AID methods, other DNA modifiers would make it 
possible to generate more diverse variations at defined 
regions. In addition, MutaT7 could generate almost all 
mutations in designed region by the nature of T7 RNAP, 
from T7 promoter to terminator. Both EvolvR and 
MutaT7 are based on chimeric mutator that is directed 
to specific regions by gRNA or T7 promoter, respectively. 
Therefore, multiplex targeting can be easily achieved by 
using multiple gRNAs or by positioning the T7 promoter 
at several positions. Depending on whether mutations 
are intended in multiple targeted windows or genome 
scale, one of the three effective mutagenesis techniques 
can be used for each purpose. EvolvR and MP technolo-
gies are especially easy to use because they do not require 
host engineering.
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Genome‑wide random mutagenesis
Although in  vivo mutagenesis has advantages over 
in  vitro methods to enhance random mutagenesis in a 
genome, it has drawbacks such as low efficiency, uncon-
trolled mutagenesis, and genomic instability. Traditional 
in  vivo mutagenesis by mutator strain also had these 
problems [52]. To overcome these huddles, Badran et al. 
developed a mutagenic system based on the mutagen-
esis plasmid (MP) carrying mechanism-guided mutator 
genes (Fig. 1i) [53]. The error-prone DNA polymerase III 
subunit, DnaQ926, was overexpressed in combination 
with genes known to conferring replication fidelity such 
as proofreading, MMR, translesion synthesis, and base 
selection to alter cellular canonical network. Although 
DnaQ926 alone showed a high mutation rate, mutagen-
esis plasmid carrying additional genes, MP6, increased 
mutation rate 63-fold higher than DnaQ926. The utility 
of the outperformed mutagenesis plasmid was demon-
strated by improving antibiotic resistance of a cell and 
to evolve T7 RNAP to recognize different promoter. 
Being adapted with phage-assisted continuous evolution 
(PACE) [54], MP6 could successfully improve soluble 
expression of protein and diversify PAM sequences rec-
ognized by Cas9 [55, 56].
Advanced DNA synthesis technology enabled writ-
ing synthetic chromosome and initiating synthetic yeast 
genome project, Sc2.0. One of the design principles in 
this project was to provide controllable genetic flex-
ibility. In addition to replace amber stop codon to TAA 
stop codon, loxPsym sequences were integrated into 
multiple sites in synthetic chromosome and used for 
scrambling chromosome under induction [57]. This syn-
thetic chromosome was named as synIXR and allows the 
SCRaMbLE, synthetic chromosome rearrangement and 
modification by loxP-mediated evolution. Induction of 
Cre recombinase in synIXR perturbed yeast phenotype 
by causing random inversions and deletions in chromo-
some (Fig. 1j). Many studies demonstrating the applica-
bility of SCRaMbLE to generate phenotypic diversity in 
yeast were reported [24, 58–64]. Other than entire chro-
mosome, a synthetic pathway can be also adopted for 
SCRaMbLE. There were studies that have used SCRaM-
bLE for tuning expression level or pathway structure 
in combination [63, 64]. By positioning loxPsym sites 
between genes or upstream and downstream of the pro-
moters, a plasmid could be subjected for SCRaMbLE 
and resulted in pathway variants. In addition to the tech-
niques to generate phenotypic diversity, a method was 
developed that efficiently identify SCRaMbLEd variants. 
Luo et  al. demonstrated ReSCuES (reporter of SCRaM-
bLEd cells using efficient selection) that used two auxo-
trophic markers; one of them was functional only before 
SCRaMbLE, and the other was only functional after 
SCRaMbLE to efficiently distinguish whether Cre was 
actively expressed or not [62]. The MP and SCRaMbLE 
methods can generate a genome-wide random mutation, 
and the mutagenesis can be occurred by induction since 
the use of an inducible promotor. Mutations accumulate 
as the duration of mutator expression increases.
Next, a technique to dynamically control a mutator 
expression was developed. Equipped with appropriate 
sensor, the mutator expression was stopped when the cell 
acquired an improved phenotype such as high chemical 
production. In feedback-regulated evolution of pheno-
type (FREP), mutation rate was programmed to control 
the mutagenic gene expression, mutD5, for the desired 
phenotype. Using a sensor recognizing a desirable phe-
notype such as metabolite production, expression of the 
mutagenic gene could be stopped at high target molecule 
concentration, but expression of the mutagenic gene 
would be induced to accelerate phenotype improvement 
when cellular concentration of target molecules gets low 
[65]. This convertible mutagenic state was adopted to 
evolve cells to resistance in acids [66].
Luan et  al. developed Genome Replication Engineer-
ing Assisted Continuous Evolution (GREACE) in which 
mutagenesis was performed with simultaneous selection 
[67]. They devised in vivo mutagenesis using proofread-
ing element library under selective conditions differing 
from the traditional mutagenesis where mutagenesis 
and selection were proceeded sequentially. This strategy 
was applied to achieve improved tolerance for organic 
solvents, organic acids, and heat [68]. The adaptive labo-
ratory evolution (ALE) is an effective method to evolve 
both model and non-model strains when appropriate 
synthetic tools are not developed. A native xylose fer-
menting yeast, Scheffersomyces stipites was evolved to 
tolerate ethanol and concentrated hydrolysate. Through 
the long term of ALE, repetitive culturing in two types of 
hydrolysates containing ethanol allowed them to screen 
mutant strains with higher tolerance in hydrolysates with 
high ethanol concentration [69]. Evolution for cells hav-
ing tolerance to toxic chemicals or growth inhibition 
products is relatively straightforward because it is pos-
sible to screen based on the growth rate change only. 
However, for higher production of general chemicals, a 
method should be able to screen the improved phenotype 
in high-throughput manner.
Acquisition of improved phenotypic variant
Screening improved strain from the library is another 
important task in evolutionary engineering. Especially, 
recently developed techniques that generate vast librar-
ies require high-throughput screening (HTS) meth-
ods to efficiently search expanded phenotypic space. 
In vivo biosensors that detect target chemicals, pH, and 
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temperature in a cell allow HTS. There are two major cat-
egories in sensing devices which are protein-based and 
RNA-based sensor, respectively. Both have been either 
discovered in nature or synthesized by various methods. 
They can be assembled with a reporter gene or a selec-
tion marker, allowing to convert various phenotypes into 
signals which can be analyzed in high-throughput man-
ner (Fig. 2).
Biosensor‑based screening
Lysine-specific biosensor consisting of lysine-specific 
transcription factor (LysG) and a reporter gene (YFP) 
was constructed and employed to screen high lysine 
producers among Corynebacterium glutamicum library 
generated by chemical mutagenesis [70]. With fluo-
rescence-activated cell sorter (FACS) analysis, highly 
improved mutant strains were screened (Fig.  2). The 
sequences of the l-lysine synthesis pathway genes and 
the entire chromosome of the mutant were also ana-
lyzed to understand the basic mechanism for improving 
l-lysine production.
There is less number of direct sensing devices than 
the number of metabolites of our interests. Therefore, 
researchers had implemented an additional genetic cas-
sette, helper enzymes, to convert targeted molecules 
into other chemicals that can be detected by previously 
developed sensor devices and imaging device [71–75] 
(Table  1). Rogers et  al. circumvented a lack of a sensor 
to detect 3-hydroxyl propionic acid (3-HP) by intro-
ducing a pathway converting 3-HP into acrylate [71]. 
Through this study, the research group also completed 
the synthesis pathway from glucose to acrylate for the 
first time. Nguyen et  al. utilized the 3-HP sensor as a 
1,3-propanediol (PDO) sensor by introducing enhanced 
α-ketoglutaric semialdehyde dehydrogenase (KGSADH) 
that can convert 1,3-PDO into 3-HP [72].
Developing biosensors expands the range of targeted 
traits that can be acquired. It is easier to create an RNA-
based biosensor than to create a TF-based biosensor. 
Moreover, compared with creating a novel sensor, modi-
fying the dynamic range and targeting binding affinity of 
existing sensors are not too difficult. pH biosensor that 
responds to different levels of pH was developed based 
on the existing pH riboswitches. Then, adaptive evolution 
was performed under different pHs with genetic cassette 
harboring pH biosensor [66]. In that genetic cassette, 
error-prone dnaQ and rfp were arranged to share a pro-
moter in opposite direction. This promoter was inverted 
by a site-specific invertase whose expression is controlled 
by pH riboswitch to allow RFP expression. Thus, the cel-
lular state was programmed the transition from a muta-
genic state expressing the mutant DnaQ into a reporting 
state expressing RFP.
As mentioned above, in  vivo biosensor has been 
applied with a high-throughput instrument to isolate 
desired phenotype from large library. Fluorescence-acti-
vated droplet sorting (FADS) was developed to reduce 
stress which was applied to cells during sorting by con-
ventional FACS. A tryptophan biosensor was constructed 
based on the tryptophan riboswitch, and the cells trans-
formed with biosensor were subjected to generate library. 
Using FADS, pico-litter-sized droplets containing each of 
tryptophan-producing cell variants were generated and 
sorted by fluorescence [76]. An alternative method was 
developed to screen metabolite producer when the tar-
geted metabolite is easily secreted out of the cells. In this 
Biosensor/selector
GFP/TetATF
GFP/TetA
Selection
pressure
Fluorescence-activated
cell sortor Cell enrichment
TF-based biosensor/selector
RNA-based biosensor/selector
Fig. 2 Biosensor/selector construction by assembling sensing module such as TF or riboswitch with reporter. The reporter gene is regulated by a 
sensing module which detects chemical, different pH, etc. then converts signals detectable in high-throughput such as fluorescence and growth 
rate under selective pressure
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case, the intracellular metabolite concentration could not 
reflect production efficiency of the cell. Thus, a chemical 
producer and a sensor cell were encapsulated in nano-
liter reactors (nLRs) and these nLRs, the alginate beads, 
were screened using complex object parametric analyzer 
and sorter (COPAS) device [77]. Because there is no need 
to change biosensor components such as plasmid, pro-
moter, RBS, or reporter gene, whole-cell biosensors can 
be easily adopted to screen a library based on a differ-
ent species. Similarly, a naringenin sensor cell could be 
used for monitoring production through co-culturing 
cells with producing cells [78]. In addition to be used 
for screening of metabolite producing cells, fluorescent 
reporter can also be used for visualizing other protein 
expression level. By in vitro translation of gfp and target 
genes in the same tube, expression level of target gene 
could be inversely correlated with the GFP fluorescence 
level since the gfp and target genes share the limited 
amount of resources for translation [79].
Selection
Tetracycline resistance gene (tetA) has been gener-
ally used as selection marker in biosensor construc-
tion (Fig. 2). TetA can be used for dual-selection system 
because tetracycline efflux pump (TetA) not only makes 
cells resistant to tetracycline, but also makes cells sensi-
tive to nickel. There are successful cases that use tetA-
based selection device to acquire novel RNA molecules 
and improved strains. TetA gene was assembled in bio-
sensors with lysine-riboswitch, naringenin-responsive 
TF, glucaric acid-responsive TF, and 3-HP-responsive 
TF to construct a selection device for the improvement 
of production of each corresponding biochemical by 
evolutionary engineering of strains [80–83]. Once the 
cells are equipped with the selection device, improved 
strains could be simply screened by enrichment culture 
because they had growth advantage under selection pres-
sure (Fig. 2). Recently, a 3-HP-responsive selection device 
was constructed and used for evolutionary engineering of 
aldehyde dehydrogenase (ALDH) [82]. The structure pre-
diction-based ALDH library was subjected to enrichment 
culture with selection device in that tetA gene expres-
sion was controlled by 3-HP-responsive TF. An improved 
variant exhibited 2.79-fold higher specific activity and the 
cell harboring this mutant showed higher 3-HP produc-
tion titer. This easy and fast isolation step can accelerate 
evolution of metabolic enzyme without expensive equip-
ment. Although many other antibiotic resistance genes 
can be used as selection marker, the dual-selection strat-
egy by a single selection marker and a resistance mech-
anism without antibiotics degradation make tetA still 
being an attractive part.
Leavitt et  al. demonstrated a strategy surrogating 
desired phenotype to other phenotype for which a bio-
sensor already existed [84]. They firstly aimed to improve 
aromatic amino acid (AAA) production using AAA bio-
sensor, and then flux was redirected to muconic acid 
based on the AAA high-producing variant. This method 
can be applied to such cases that the sensors responding 
to the final products are difficult to be developed.
Reduced production efficiency has usually been 
observed during the long-term cultivation. This is caused 
by stochastic gene expression that generates phenotypic 
perturbation without genetic alterations. The synthetic 
addiction strategy keeps populations of highly produc-
ing cells through arresting growth of nonproducing cells 
[85]. To synthetically addict cells to target product, essen-
tial genes of producer are controlled under the product 
sensing device. If productivity decreases by some reasons 
such as an epigenetic expression change or an evolution-
ary gained mutation for toxic product, growth of the cells 
equipped with addiction device will be arrested. The syn-
thetic addiction of cells to mevalonic acid (MVA) was 
accomplished using MVA sensing device and essential 
genes, folP and glmM.
Biomolecule enrichment
The concept of continuously evolving biomolecules 
in vitro was demonstrated by Wright and Joyce [86]. They 
targeted RNA ribozyme functioning as RNA ligase to 
evolve. Ribozyme variants catalyzed ligation with a piece 
of RNA substrate fused to T7 RNA polymerase promoter. 
The ligation reaction was beneficial to amplify itself 
when T7 RNAP was added; therefore, the evolved ligase 
ribozymes were dominated in the reaction mixture. How-
ever, it was difficult to generalize in vitro evolution strat-
egy. The target activity was limited in cis manner since all 
variants were in the same pool. Compartmentalizing each 
genotype variant is required to analyze genotype–pheno-
type relationship in high-throughput manner. Tawfik and 
Griffiths et  al. [87] developed a compartmentalization 
technique which allowed reproduction of genotype–phe-
notype linkage in vitro. This encapsulation technique was 
adopted to compartmentalize self-replication (CSR) [88] 
in which a highly active DNAP can generate more cop-
ies of DNA in the emulsion without cross-reaction. They 
screened thermo-tolerant variant at higher temperature 
of denaturing stage of PCR and screened heparin (inhibi-
tor for many of polymerases)-tolerant variant through 
PCR under heparin containing mixture.
Ellefson et  al. expanded evolution targets to protein–
DNA interaction (orthogonal T7 RNAP) and a pair of 
tRNA synthetase/suppressor tRNAs [89]. They demon-
strated that compartmentalized partnered replication 
(CPR) based on the genetic circuit which links desired 
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phenotype to taq-polymerase expression could evolve 
RNA polymerase and orthogonal translation system effi-
ciently (Fig.  3) [90]. Recently, using a regulatory circuit 
as a partner, iterative CPR was performed to evolve tran-
scription regulator, Trp repressor, to bind noncanonical 
effector molecule or to recognize novel operators [91].
Coupling enrichment to the function of interest makes 
continuous evolution easy and fast. Esvelt et al. demon-
strated phage-assisted continuous evolution (PACE) in 
which evolved phenotypes were linked to generate more 
offspring [54]. In PACE, effective mutations increased 
pIII production in host cells and resulted in more infec-
tious phage progeny (Fig.  3). They examined the cou-
pling of infectious phage generation with diverse protein 
functions such as polymerase activity, protein–peptide 
binding, and recombinase activity. Constant flow sys-
tem effectively washed out nonfunctional molecules. 
Fast phage life-cycle accelerated the evolution rate and 
resulted in 12 evolution rounds per day. It could last 
1 day without human intervention.
PACE can rapidly evolve diverse protein functions, 
if a genetic circuit is devised, which links pIII synthesis 
with desired functions. Badran et al. screened improved 
Cyr1Ac, a wildly used insecticidal protein, also known 
as Bt toxin, with genetic circuit by coupling protein–
protein interaction to pIII synthesis [92]. They designed 
that pIII could be produced when evolved rpoZ-Bt toxin 
binds to TnCAD, an insect cell membrane cadherin-like 
receptor from cabbage looper (Trichoplusia ni) (Fig. 4a). 
The value of proteases that recognize specific targets has 
been increased in both commercial enzyme and thera-
peutics industry. Packer et  al. evolved TEV protease to 
cleave a completely new target amino acid sequence [93]. 
T7 RNAP was fused with T7 lysozyme through a linker 
that could be only cleaved by evolved proteases (Fig. 4b). 
PACE allowed to find a novel TEV-derived protease 
which could cleave human IL-23 without loss of activity 
to the consensus substrate. Meanwhile, these results indi-
cated the need for negative selection strategy to eliminate 
activity to unintentional substrates. Bryson et  al. also 
used PACE to evolve orthogonal aminoacyl-tRNA for the 
incorporation of noncanonical amino acids (ncAAs) [94]. 
They performed PACE using T7 RNAP or pIII containing 
amber codons at a position, so that premature termina-
tion can be occurred if ncAAs are not incorporated by 
evolved aaRS/tRNA (Fig. 4c). In addition, negative selec-
tion step utilizing pIII-neg which was non-infectious 
pIII expressed without ncAAs, reduced unintentional 
function such as an activity on endogenous amino acids. 
Moreover, PACE employed to modify a split RNAP sys-
tem to rewire assembly of split parts into proximity-
dependent manner. In order to expand the uses of split 
RNAP in biosensor, Pu et  al. fused leucine zipper pep-
tide into each of RNAP parts, and N terminus of RNAP 
was subjected to mutagenesis [95]. The mutated RNAP 
was selected only when assembly of RNAP was assisted 
Biomolecule enrichment
Protein solubility
pIII protein-based propagation
Cloning &
transformation
Partner
DNA Pol.
dNTPs, primers
Partner
E. coli
taq polymerase-basd propagation
Protein-protein interaction
(target-toxin binding,
  protease cleavage site)
Protein-DNA interaction
(TF-operator, Cas9-PAM,
 RNAP-promoter)
Protein activity
(DNA polymerase,
aaRS activity)
converting phenotype
Infectious
progeny
Non-infectious
progeny
E. coli
Infection & release progeny
Fig. 3 DNAs harboring beneficial mutations are propagated by compartmentalization technique and PACE. Genetic cassettes convert diverse 
protein functions such as protein–protein binding, protein–DNA interaction, protein specific activity, and protein solubility to changes in the 
expression levels of taq-polymerase or of phage infection protein. In the taq-polymerase case, the amount of amplified target product depends 
on taq-polymerase content which is expressed in a cell. Each cell containing a plasmid carrying target DNA and taq-polymerase is encapsulated 
together with PCR mixture (PCR buffer, dNTPs, primers). During emulsion PCR, cells are disrupted and expose plasmid as template and expressed 
taq-polymerase. In M13 protein III (pIII) case, expression of pIII is regulated. When beneficial mutations are occurred and increasing pIII expression, 
phage carrying these mutations can generate more progeny
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by peptide–peptide interaction and named as activity-
responsive (AR) RNAP system. The applicability of AR 
system was validated through developing both light and 
small-molecule biosensors by replacing the protein–pro-
tein interaction domain with domains conferring light 
and rapamycin responsive dimerization, respectively.
PACE was also applied to improve protein–DNA inter-
action in CRISPR system. To expand PAM sequence to 
various target positions, Cas9 protein was subjected 
into evolution. The gene cassette was constructed for 
pIII expression only when dCas9 binds to a protospacer 
with a modified PAM sequence [55]. Recognition of new 
PAM by dCas9-rpoZ fusion protein triggers transcription 
of pIII by E. coli RNAP (Fig. 4e). Through PACE, xCas9 
having enhanced binding affinity, broadened PAM 
sequences, and reduced off-target activity was screened. 
The PAM specificity of Cas9 has been regarded as huddle 
in CRISPR assisting recombineering or genome editing 
applications. Therefore, xCas9 will be adopted for various 
applications utilizing the CRISPR system.
The expression of soluble proteins is essential for the 
recombinant protein production and application. Thus, 
there have been various strategies to improve protein 
solubility. The traditional methods optimizing growth 
conditions such as temperature, medium, inducer con-
centration, induction time, and co-expression of molec-
ular chaperones as well as fusion of folding tag are still 
applied for enhance protein solubility [96, 97]. In spite 
of many studies, the difficulty in protein folding is not 
easy to be solved just using environmental optimiza-
tion, because the folding is largely affected by the prop-
erties of proteins such as the amino acid sequences. The 
directed evolution may improve protein solubility, but 
since the size of the library is so large, an efficient screen-
ing method should be followed. Utilizing folding report-
ers was one of the strategies to screen protein variants 
in high-throughput manner. However, fusion of large 
domains sometimes causes loss of function of partner 
protein. Split RNA polymerase (T7 RNA polymerase 
small residue and rpoZ) was used as a reporter of solu-
ble expression [56]. By fusion of a target protein with the 
small fragment of split RNAP (T7n and rpoZ), soluble 
expression variants triggered pIII expression by expos-
ing the RNAP domain to bind with another fragment 
(Fig. 4d). They also used split pIII system to develop AND 
gate to allocate each function of interest. Protein binding 
activity and soluble expression were linked to the expres-
sion of each pIII part.
Conclusions
Devising gene cassettes or genetic circuits that perform 
specific functions has long been performed in synthetic 
biology field. Synthetic biology tools have been devel-
oped to generate mutations in the cell with different 
mutation rate, mutation range (specific regions or entire 
genome), multiplexity, and whether the altered pheno-
types are permanent or removable. The power of these 
tools was usually examined through improving specific 
phenotypes such as production of colored chemicals or 
tolerance. However, industrially interesting chemicals 
are generally indistinguishable chemicals or provide no 
growth benefit to producers, and thus the step of acquir-
ing improved variants from a huge library is considered 
as a major limitation.
Thus, the development of synthetic systems that con-
vert specific chemical concentration or desired protein 
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functions into selectable phenotype is another key for 
successful evolutionary engineering. For example, the 
use of biosensor that links the metabolite concentration 
to detectable phenotype such as fluorescence and resist-
ance to selection pressure was exemplified for lysine, 
naringenin, glucaric acid, mevalonic acid, 3-HP, and so 
on. Therefore, discovering natural regulators and devel-
oping new regulators using synthetic parts will empower 
the biosensor-based screening/selection step. Moreo-
ver, well-designed accessory plasmids for PACE have 
expanded target functions to various properties. Multiple 
traits can also be satisfied by complex logic gates.
Altogether, the advance in synthetic biology pro-
vides efficient tools for the two main steps of evolution-
ary engineering: genetic perturbation and acquisition 
of improved phenotype. Now, it is pushed to identify 
effective changes from randomly generated mutations. 
Analyzing the consequences of mutations on cellular/
protein functions is an additional step for evolutionary 
engineering. Recently, facilitated omics technology has 
assisted evolutionary engineering. Using next-generation 
sequencing, tracking genome-wide multiple mutations is 
plausible. Moreover, the analysis of accumulated muta-
tion in the evolved populations allows to study evolution-
ary paths.
The growing interest of bioindustry demands much 
complex phenotype or use of non-model strain. There-
fore, the utility of evolutionary engineering which can 
optimize cellular phenotype even without intensive bio-
logical information will increase. The synthetic genetic 
tools will accelerate evolution of much diverse pheno-
types in various microbes.
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